Isotretinoin Ennogen Ip (Isotretinoin)

Isotretinoin acts by binding to retinoic acid receptors in skin cells, which reduces the size and activity of sebaceous glands, lowers sebum production, normalizes follicular keratinization, and exerts anti‑inflammatory effects, thereby targeting the underlying causes of severe acne.

The dose of Isotretinoin Ennogen Ip is individualized by the prescribing physician based on the severity of acne, patient weight, and tolerance. Typical regimens range from 0.5 mg/kg to 1 mg/kg per day, but exact dosing must be determined by a qualified healthcare professional.

Isotretinoin is classified as pregnancy category X because it is highly teratogenic. It must not be used by pregnant women or women who may become pregnant. Breastfeeding is also contraindicated, as the drug can be excreted in milk and may harm the infant.

To order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Unlike topical agents or oral antibiotics, isotretinoin addresses the root causes of severe acne by reducing sebum output and normalizing follicular keratinization. It is generally reserved for cases that have failed other therapies because of its higher efficacy and potential for serious adverse effects.

Store the product below 25 °C in its original container, protecting it from moisture and direct light. Keep the packaging tightly closed and out of reach of children. No refrigeration is required for this oral formulation.

Isotretinoin Ennogen Ip is taken orally, usually with a meal to improve absorption. The tablet or capsule should be swallowed whole with water and not crushed or chewed. Patients should follow the dosing schedule prescribed by their healthcare provider.

The most serious risks include severe depression or suicidal thoughts, inflammatory bowel disease, hepatotoxicity (elevated liver enzymes), and teratogenic effects leading to birth defects. Any new psychiatric symptoms, persistent abdominal pain, or signs of liver dysfunction require immediate medical evaluation.

Individuals who are pregnant, planning pregnancy, or not using effective contraception should not use isotretinoin. Patients with pre‑existing liver disease, uncontrolled hyperlipidaemia, or a history of severe psychiatric disorders should avoid the drug unless a specialist determines that benefits outweigh risks.